Evidence map›Paper›PMID 41815280›Full record

ArticleBlood science (Baltimore, Md.)2026

Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report.

Maria Antonia De Francesco, Rossella Ribolla, Alessandra Sottini, Diego Bertoli, Carlotta Giupponi, Ottavia Bonuccelli, Roberto Bresciani, Alessandra Tucci, Giorgio Biasiotto

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood science (Baltimore, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Antonia De FrancescoDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
Rossella RibollaDepartment of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
Alessandra SottiniDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
Diego BertoliDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
Carlotta GiupponiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
Ottavia BonuccelliDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
Roberto BrescianiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.
Alessandra TucciDepartment of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
Giorgio BiasiottoDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41815280
PMCPMC12975212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.